List of insiders holdings for Tectonic Therapeutic Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
ATLAS VENTURE ASSOCIATES X L.P. 10% Owner | 2020-02-18 21:51:43 | 4,756,478 0 | 4,756,478 | Form 4 |
SPRINGER TIMOTHY A Director 10% Owner | 2024-10-24 17:12:09 | 4,593,121 0 | 4,593,121 | Form 13D |
Requadt Scott Director | 2018-06-25 18:18:34 | 0 2,962,325 | 2,962,325 | Form 4 |
Blackstone Holdings II L.P. Blackstone Clarus III L.L.C. Blackstone Holdings I Blackstone Group L.P. Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner | 2019-01-15 09:24:04 | 0 2,962,325 | 2,962,325 | Form 3 |
SVLSF VI LLC SV Life Sciences Fund VI L.P. SV Life Sciences Fund VI Strategic Partners L.P. SV Life Sciences Fund VI (GP) L.P. 10% Owner | 2021-02-16 16:02:55 | 1,417,204 0 | 1,417,204 | Form 13D |
MCGUIRE TERRANCE Director | 2024-06-25 16:23:25 | 1,157,976 0 | 1,157,976 | Form 13D |
Leonard Braden Michael Former 10% owner of AVROBIO | 2024-06-25 13:42:11 | 66,666 800,710 | 867,376 | Form 4 |
Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC See Remarks | 2019-07-29 21:11:33 | 0 810,811 | 810,811 | Form 3 |
REICIN ALISE Chief Executive Officer | 2024-12-06 17:19:48 | 184,297 124,530 | 308,827 | Form 4 |
MACKAY GEOFFREY President & CEO | 2023-02-10 17:08:28 | 300,667 0 | 300,667 | Form 4 |
Cortis Christian Chief Operating Officer | 2024-06-24 16:16:36 | 201,133 0 | 201,133 | Form 4 |
Ruddy Marcella K. Chief Medical Officer | 2024-06-24 16:22:31 | 176,415 0 | 176,415 | Form 4 |
Golipour Azadeh Chief Technology Officer | 2024-02-05 20:01:02 | 167,871 0 | 167,871 | Form 4 |
Dorton Katina Chief Financial Officer | 2018-10-10 18:11:06 | 158,318 0 | 158,318 | Form 4 |
Ostrowski Erik Interim CEO, President and CFO | 2024-02-05 19:57:30 | 149,534 0 | 149,534 | Form 4 |
Mason Christopher Chief Scientific Officer | 2021-06-14 18:03:04 | 125,000 0 | 125,000 | Form 4 |
Avruch Steven Chief Legal Officer | 2024-02-05 19:56:00 | 120,521 0 | 120,521 | Form 4 |
Lochner Daniel Chief Financial Officer | 2024-06-24 16:18:22 | 118,000 0 | 118,000 | Form 4 |
Ridha Essra Chief Medical Officer | 2024-02-05 19:59:27 | 114,380 0 | 114,380 | Form 4 |
Schwabish Marc Chief Business Officer | 2024-12-11 16:21:49 | 91,214 0 | 91,214 | Form 4 |
Petersen Deanna M Chief Business Officer | 2023-02-10 17:16:35 | 86,667 0 | 86,667 | Form 4 |
Volck Birgitte President of R&D | 2020-03-06 16:38:02 | 76,000 0 | 76,000 | Form 4 |
Atlas Venture Fund X L.P. ATLAS VENTURE ASSOCIATES X L.P. Atlas Venture Associates X LLC 10% Owner | 2024-10-28 18:08:43 | 67,567 0 | 67,567 | Form 13D |
Escolar Diana Chief Medical Officer | 2021-06-14 17:55:42 | 50,000 0 | 50,000 | Form 4 |
McNamara Peter Chief Scientific Officer | 2024-12-05 16:32:07 | 48,647 0 | 48,647 | Form 4 |
Vitorovic Stefan Director | 2024-06-24 16:35:35 | 11,760 27,774 | 39,534 | Form 4 |
KREHER NERISSA Chief Medical Officer | 2018-10-10 18:05:27 | 27,571 0 | 27,571 | Form 4 |
Tipirneni Praveen P. Director | 2024-06-24 16:32:33 | 26,963 0 | 26,963 | Form 4 |
Farfel Gail M Director | 2023-06-08 16:28:51 | 17,643 0 | 17,643 | Form 4 |
PAIGE CHRISTOPHER Director | 2023-06-08 16:31:34 | 17,643 0 | 17,643 | Form 4 |
Vickers Philip J. Director | 2023-06-08 16:29:53 | 17,643 0 | 17,643 | Form 4 |
Booth Bruce Director | 2023-06-08 16:27:43 | 17,643 0 | 17,643 | Form 4 |
Jenkins Annalisa Director | 2023-06-08 16:26:42 | 17,643 0 | 17,643 | Form 4 |
CLARK IAN T Director | 2023-06-08 16:25:47 | 17,643 0 | 17,643 | Form 4 |
Donenberg Phillip B. Director | 2024-06-24 16:37:33 | 11,760 0 | 11,760 | Form 4 |
Resnick Joshua Director | 2018-06-20 20:04:18 | 0 0 | 0 | Form 3 |
Clarus Lifesciences III L.P. Clarus Ventures III GP L.P. 10% Owner | 2019-08-05 18:52:38 | 0 0 | 0 | Form 13D |
Clarus Lifesciences III L.P. Clarus Ventures III GP L.P. Clarus Ventures III LLC 10% Owner | 2019-08-05 18:52:38 | 0 0 | 0 | Form 13D |